-
Jul 20, 2020
AmerisourceBergen (ABC) and Good Neighbor Pharmacy (GNP) continue to engage with Members of Congress on pharmacy priorities including empowering pharmacists to be able to provide and be reimbursed for COVID-19 testing and vaccination once available.
Full story
-
Jun 16, 2020
AmerisourceBergen Government Affairs team members Beth Mitchell (Senior Director, Government Affairs) and Ashley O’Sullivan (Senior Manager, Legislation & Policy) recently recorded a Good Neighbor Pharmacy Connect podcast to discuss all things advocacy for independent pharmacies.
Full story
-
Jun 05, 2020
On Wednesday 6/3, the U.S. Senate unanimously passed the House passed Paycheck Protection Program (PPP) Flexibility Act, which provides key changes to the existing Payment Protection Program (PPP). President Trump signed the PPP Flexibility Act into law on 6/5. AmerisourceBergen and Good Neighbor Pharmacy are very pleased that Congress acted to make necessary changes to PPP.
Full story
-
Jun 02, 2020
Recently, the California Department of Consumer Affairs issued an Order to allow approximately 6,500 licensed pharmacies in the state to begin performing COVID19 tests without having to coordinate with a patient’s diagnosing or primary care provider. The Order waives sections of California’s Business and Professions Code that interfere with pharmacists’ ability to authorize tests for COVID 19, including a waiver of provisions that would prevent pharmacists from physically collecting the specimens.
Full story
-
May 29, 2020
Office of the General Counsel (OGC) whether the Public Readiness and Emergency Preparedness (PREP) Act preempts state licensing laws that restrict the ability of pharmacists to order and administer COVID-19 diagnostic tests where the Department of Health and Human Services (HHS) has expressly authorized pharmacists, under the PREP Act, to order and administer those tests
Full story
-
May 11, 2020
On Thursday, May 7, a letter signed by Good Neighbor Pharmacy (GNP) and more than 240 patient and provider groups, trade associations, and healthcare companies, was sent to Congressional leadership urging immediate action on DIR fee reform. Link to letter in the article.
Full story
-
Apr 29, 2020
On Monday, April 27, a bipartisan letter was sent to U.S. House and Senate leadership urging for the inclusion of pharmacy DIR reform in the next COVID-19 relief package. The bipartisan House letter, led by Reps. Buddy Carter (R-GA), Peter Welch (D-VT), Raja Krishnamoorthi (D-IL), John Rose (R-TN), Vicente Gonzales (D-TX), and Doug Collins (R-GA), garnered 115 signers in the House of Representatives, the most number of signatures ever on a DIR fee focused Congressional letter.
Full story
-
Apr 28, 2020
As scientists are working around the clock to develop a COVID-19 vaccine, GNP and ABC are collaborating with ADPC members to call on states to remove barriers that prevent pharmacists from administering vaccines. Learn more here and read a letter the coalition recently sent to HHS Assistant Secretary for Health, Admiral Brett Giroir, M.D.
Full story
-
Apr 24, 2020
On April 8th the U.S. Department of Health and Human Services (HHS) made the historic decision to allow pharmacists to order and administer FDA approved COVID-19 tests. Empowering pharmacists to test for COVID-19 is a policy GNP and ABC have advocated for, and we are pleased to see this recent HHS guidance. However, in California pharmacists are still unable to administer COVID-19 tests due to existing state restrictions.
Full story
-
Apr 24, 2020
On April 8th the U.S. Department of Health and Human Services (HHS) made the historic decision to allow pharmacists to order and administer FDA approved COVID-19 tests. Empowering pharmacists to test for COVID-19 is a policy GNP and ABC have advocated for, and we are pleased to see this recent HHS guidance. However, in New York pharmacists are still unable to administer COVID-19 tests due to existing state restrictions.
Full story